Stacking Protocols Critical: Community sources warn against combining multiple senolytics simultaneously and describe allowing adequate recovery between senolytic courses (minimum 4-6 weeks), running each compound individually first, and monitoring bloodwork (CBC, CMP, inflammatory markers) between courses
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
Dedication to Safety: Limitless Life provides research peptides for qualified peptide researchers
Jason P
Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis